Effect of prior bevacizumab therapy in patients with platinum-sensitive recurrent ovarian carcinoma (ROC) in the phase 3 study ARIEL3 Meeting Abstract
| Authors: | Oza, A.; Coleman, R. L.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Banerjee, S.; Goble, S.; Cameron, T.; Ledermann, J. A. |
| Abstract Title: | Effect of prior bevacizumab therapy in patients with platinum-sensitive recurrent ovarian carcinoma (ROC) in the phase 3 study ARIEL3 |
| Meeting Title: | 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 28 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2018 Sept 14-16 |
| Meeting Location: | Kyoto, Japan |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2018-09-01 |
| Start Page: | 45 |
| End Page: | 46 |
| Language: | English |
| ACCESSION: | WOS:000471152400036 |
| PROVIDER: | wos |
| PUBMED: | 30212387 |
| DOI: | 10.1136/00009577-201809002-00001 |
| Notes: | Meeting Abstract: IGCS8-0758 -- Source: Wos |
